Literature DB >> 9032203

Abnormal skeletal muscle oxidative capacity after lung transplantation by 31P-MRS.

A B Evans1, A J Al-Himyary, M I Hrovat, P Pappagianopoulos, J C Wain, L C Ginns, D M Systrom.   

Abstract

Although lung transplantation improves exercise capacity by removal of a ventilatory limitation, recipients' postoperative maximum oxygen uptake (VO2max) remains markedly abnormal. To determine if abnormal skeletal muscle oxidative capacity contributes to this impaired aerobic capacity, nine lung transplant recipients and eight healthy volunteers performed incremental quadriceps exercise to exhaustion with simultaneous measurements of pulmonary gas exchange, minute ventilation, blood lactate, and quadriceps muscle pH and phosphorylation potential by 31P-magnetic resonance spectroscopy (31P-MRS). Five to 38 mo after lung transplantation, peak VO2 was decreased compared with that of normal control subjects (6.7 +/- 0.4 versus 12.3 +/- 1.0 ml/min/kg, p < 0.001), even after accounting for differences in age and lean body weight. Neither ventilation, arterial O2 saturation nor mild anemia could account for the decrease in aerobic capacity. Quadriceps muscle intracellular pH (pH(i)) was more acidic at rest (7.07 +/- 0.01 versus 7.12 +/- 0.01 units, p < 0.05) and fell during exercise from baseline values at a lower metabolic rate (282 +/- 21 versus 577 +/- 52 ml/min, p < 0.001). Regressions for pH(i) versus VO2, phosphocreatine/inorganic phosphate ratio (PCr/Pi) versus VO2, and blood lactate versus pH(i) were not different. Among transplant recipients, the metabolic rate at which pH(i) fell correlated closely with VO2max (r = 0.87, p < 0.01). The persistent decrease in VO2max after lung transplantation may be related to abnormalities of skeletal muscle oxidative capacity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032203     DOI: 10.1164/ajrccm.155.2.9032203

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Inferences from pulmonary O2 uptake with respect to intramuscular [phosphocreatine] kinetics during moderate exercise in humans.

Authors:  H B Rossiter; S A Ward; V L Doyle; F A Howe; J R Griffiths; B J Whipp
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

2.  Skeletal muscle strength and endurance in recipients of lung transplants.

Authors:  Sunita Mathur; Robert D Levy; W Darlene Reid
Journal:  Cardiopulm Phys Ther J       Date:  2008-09

3.  Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis.

Authors:  C Pinet; P Scillia; M Cassart; M Lamotte; C Knoop; C Mélot; M Estenne
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

4.  Cardiopulmonary exercise testing in lung transplantation: a review.

Authors:  Katherine A Dudley; Souheil El-Chemaly
Journal:  Pulm Med       Date:  2012-05-14

5.  Pulmonary oxygen uptake and muscle deoxygenation kinetics during heavy intensity cycling exercise in patients with emphysema and idiopathic pulmonary fibrosis.

Authors:  Melitta A McNarry; Nicholas K Harrison; Tom Withers; Narendra Chinnappa; Michael J Lewis
Journal:  BMC Pulm Med       Date:  2017-01-31       Impact factor: 3.317

Review 6.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

7.  Exercise training for adult lung transplant recipients.

Authors:  Ruvistay Gutierrez-Arias; Maria José Martinez-Zapata; Monica C Gaete-Mahn; Dimelza Osorio; Luis Bustos; Joel Melo Tanner; Ricardo Hidalgo; Pamela Seron
Journal:  Cochrane Database Syst Rev       Date:  2021-07-20

8.  Replicability of Physical Exercise Interventions in Lung Transplant Recipients; A Systematic Review.

Authors:  Ruud H Knols; Nicolas Fischer; Dario Kohlbrenner; Anastasios Manettas; Eling D de Bruin
Journal:  Front Physiol       Date:  2018-07-20       Impact factor: 4.566

Review 9.  [Lung transplantation. Indications, long-term results and special impact of follow-up care].

Authors:  M Dierich; T Fuehner; T Welte; A Simon; J Gottlieb
Journal:  Internist (Berl)       Date:  2009-05       Impact factor: 0.743

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.